immunosorbent assay (GM-EIA) was accepted as an initial screening tool for invasive aspergillosis. Various schemes of nucleic acid amplifi cation have been suggested by a number of studies. Our group has developed a method to detect 18S ribosomal RNA (rRNA) using nucleic acid sequence based amplifi cation using molecular beacon(MB-NASBA) and have reported a cut-off value for the clinical diagnosis of IA [4,5].
Introduction
Invasive aspergillosis (IA) is one of the major infectious complications in patients with hematologic malignancy who received cytotoxic chemotherapy or transplantation [1] . Because of its high fatality, early detection is the key to successful treatment [2] . However, the use of conventional blood culture is almost always negative for Aspergillus species [2, 3] . Therefore, non-culture based detection methods could become the main diagnostic tools for IA. Several methods have been evaluated and used to detect nucleic acids or antigens from Aspergillus species. For example, galactomannan enzyme
Materials and methods

Fungal culture and nucleic acids
A. fumigatus ATCC16424, IFO30870, A. fl avus KCTC6984, A. terreus ATCC10690, and A. niger ATCC 9029 were cultured on Sabouraud ' s dextrose agar at 37 ° C for 2 or 3 days.
The total RNA and genomic DNA from each strain were used to construct control RNA employing in vitro transcription and to evaluate the newly designed NASBA. The genomic DNA and total RNA of each strain were extracted using MasterPure Yeast DNA purifi cation kit and MasterPure RNA purifi cation kit (Epicentre, Wisconsin, USA), respectively, following the manufacturer ' s instruction. For the calculation of cut-off value, nucleic acids were extracted from 20 blood samples of healthy volunteers using RNeasy mini kit (Qiagen, GmbH, Germany).
In silico study and the design of primers and probes
The nucleotide sequences of Aspergillus 18S rRNA are homologous to those of human 18S rRNA. The comparison of the alignment between them was performed with ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2) [6] in order to design primers and probes for Aspergillus 18S rRNA which could avoid non-specifi c interaction with human 18S rRNA. We designed new primers and probes for FRET-NASBA of Aspergillus 18S rRNA with Light Cycler probe design software 2.0 (Roche, Mannheim, Germany) ( Table 1 ). The nonspecifi c interaction with human 18S rRNA of newly designed primers for FRET-NASBA and the previous primers [7] was tested using in silico PCR (http://genome.ucsc.edu/) and BLAST (http://blast.ncbi. nlm.nih.gov).
In vitro transcription of control RNA from the genomic DNA of Aspergillus strains
The target DNA template was amplifi ed by PCR with NASBA primers (Table 1 ) from the genomic DNA of each strain. The conditions of PCR were as follows: 5 min at 94 ° C; 30 cycles of 1 min at 94 ° C, 30 sec at 55 ° C, and 30 sec at 72 ° C; and 10 min at 72 ° C. The size of each amplicon was 161 bps. The amplicons were purifi ed with QIAquick PCR purifi cation kit (Qiagen, GmbH, Germany). The purity was examined by agarose gel electrophoresis and spectrophotometer. The purifi ed amplicons were used as a template for T7 RNA polymerase. RNA polymerization was performed using MAXIxcript kit (Ambion, Austin, TX, USA). Briefl y, 1 ug of DNA was added to the reaction mixture containing 10X buffer and rNTPs and incubated at 37 ° C for 1 h. Then, 1 ul of DNaseI was added to the mixture and incubated at 37 ° C for 15 min. The reaction was stopped by adding 1 ul of 0.5M EDTA. Each in vitro transcript was purifi ed by NucAway Spin Columns (Ambion, Austin, TX, USA) and each A260 value was calculated based on the copy number of the transcripts. Samples were diluted tenfold, ranging from 1 fmol/ μ l to 0.0001 amol/ μ l (representing 6 ϫ 10 8 to 6 ϫ 10 copies/ μ l).
FRET-NASBA on LightCycler 480 system (LC480)
Except for the manufacturer ' s enzyme diluent, NASBA was primarily performed using the Nuclisens Basic Kit (BioM é rieux Korea, Seoul, Korea), real-time monitored with the LC480 system (Roche, Mannheim, Germany). Instead of the manufacturer ' s enzyme diluent, an inhouse enzyme diluent of 1.5 M Sorbitol and 10 mM Tris-HCl (pH 8.3) was used in this study. Briefl y, 2 ul of target RNA was added to each 10 ul of reagent/KCl (80 mM)/primers and the probes mixture (Table 1; hybridization probes or molecular beacons, 200 nM respectively). After that, the reaction mixture was incubated at 65 ° C for 2 min to denature the secondary structure of RNA and immediately cooled to 41 ° C for 2 min for annealing primers. Then, 5 ul of enzyme mixture containing avian myeloblastosis virus (AMV) retrotranscriptase, RNase H and T7 RNA polymerase was added to the mixture. In the case of 2 step NASBA, additional reverse transcription reactions were performed by adding 3U of AMV-RT (Takara Korea Seoul, Korea) 
Assessing the previous Aspergillus 18S rRNA MB-NASBA on the platform of the LC480 system
The previous MB-NASBA [7] was tried on the platform of the LC480 system. The cut-off value for TTP of MB-NASBA was determined to be 1.571 on the LC 480 system. The coeffi cient of determination ( R 2 ) of the linear relationship between TTP and the transcript using 10 3 to 10 8 copies was 0.940 ( Fig. 2A) . MB-NASBA showed 10 -2 amol/ μ l (6 ϫ 10 3 copies/ μ l) of the 100% sensitivity. These results suggest that quantitative NASBA (Q-NASBA) could work on the LightCycler system on which diverse wavelengths could be detected. (Fig. 2C ).
Assessing new Aspergillus 18S rRNA FRET-NASBA on the platform of LC480 system
We designed a new Aspergillus 18S rRNA NASBA monitored by FRET with hybridization probes to increase the accuracy or decrease non-specifi c results. The primers and probes in this assay were designed to avoid possible binding to human transcripts (Table 1) . For real-time monitoring, it to primers-templates mixture of NASBA at 41 ° C to increase the sensitivity before the NASBA reaction (65 ° C reaction). The reaction was performed at 41 ° C on a LightCycler 480 system (Roche, Mannheim, Germany) using 90 cycles with 1 min acquisition at a 610-nm wavelength.
The cut-off values of MB-and FRET-NASBA were determined to be 1.671 times and 2.019 times the mean of the negative controls, respectively, according to the manufacturer ' s instructions. Time to positivity (TTP) was defi ned as the time at which the target and IC amplifi cation curves passed the cut-off values.
Comparison of RNA copies by FRET-NASBA with those by MB-NASBA on clinical specimen
Seventeen specimens (whole blood) obtained from patients with probable invasive aspergillosis were tested for the FRET-and MB-NASBA. RNA copies were calculated and correlation coeffi cient between these two methods was determined.
Results
The analysis of primers and probes in the previous
Aspergillus 18S rRNA NASBA with in silico study
The alignment between the nucleotide sequences of human and Aspergillus 18s rRNA by ClustalW2, showed 75.6% of homology. But Asp2.1 and Asp1.2 primers [7] were highly homologous to those of human 18s rRNA, with identical 3 ′ ends (Fig. 1, ref|NR_003286.1| ). Moreover, in silico PCR results (http://genome.ucsc.edu/) showed that they could be highly homologous to those of other parts of the human genome ( Fig. 1 . chromosome Y and 2). Aspergillus 18S rRNA NASBA has been specially designed for the diagnosis of aspergillosis. Fig. 1 The homology of the previous NASBA primers to the nucleotide sequences of Aspergillus fumigatus (AB008401), human genome (chrY:10628845-10629047 and chr2:132846672-132846880), and transcript (ref|NR_003286.1|) from in silico studies. It was performed with the comprehensive analysis of ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2) in silico PCR (http://genome.ucsc.edu/) and BLAST (http://blast.ncbi.nlm.nih.gov).
was assayed on the LC480 system (Roche) which has a wide fl uorescence spectrum and a high sensitivity. The concentration of in vitro 18s rRNA transcripts was approximately 1.5 ϫ 10 12 copies/ μ l. Diluted transcripts (10 8 -10 1 copies/ μ l) were used as templates for FRET-NASBA. The cut-off value for the time to positivity (TTP) of FRET-NASBA was determined to be 0.260. The R 2 of the linear relationship between TTP and the transcript using 10 4 to 10 8 copies was 0.934 (Fig. 3A) . FRET-NASBA showed 10 -1 amol/ μ l (6 ϫ 10 4 copies/ μ l) of the 100% sensitivity. A standard curve for the conidia number (10 4 -10 8 conidia) of A. fumigatus showed a good fi t with R 2 values of 0.9551 (Fig. 3B) and R 2 of standard curves of A. fl avus , A. terreus , and A. niger were 0.7798, 0.9539, and 0.8695, respectively (Fig. 3C, 3D , and 3E).
Correlation between MB-and FRET-NASBA
RNA copies were calculated from each TTP values using both methods. As Fig. 4 showed, there was a good correlation (r ϭ 0.825, P Ͻ 0.01) between MB-and FRET-NASBA.
Discussion
NASBA is an isothermal assay which selectively amplifi es target RNA through the action of multiple enzymes (avian myeloblastosis virus reverse transcriptase, AMV-RT, T7 RNA polymerase, and RNase H) [8] . NASBA has been used with end-point detection, by enhanced chemiluminescence (ECL), or real-time detection by molecular beacon (MB), which can be used as a quantifi cation assay [7,9 -13] .
Quantitative Aspergillus 18S rRNA NASBA has usually employed MBs which are hairpin stem-loop probes labeled with a fl uorophore and a quencher at either end. When an MB hybridizes with a target nucleic acid, the fl uorophore separates from the quencher and emits fl uorescence.
In other probe systems, the fl uorescence resonance energy transfer (FRET) technology using hybridization probes usually relies on two fl uorescence probes, a donor and an acceptor. When they hybridize together to targets in the strict distance (1 -5 bases), an energy transfer occurs between the fl uorescent dyes, leading to an emission of fl uorescent light from the acceptor probe. As hybridization probes can hybridize more sequences than single probe systems, they could theoretically be expected to increase the specifi city of the test.
Therefore, we attempted to apply FRET technology to NASBA (FRET-NASBA), and compare it to real time monitoring by MBs (MB-NASBA). Also, we used the LightCycler system (Roche Diagnostics, Mannheim, Germany) as the universal platform for NASBA.
There has been a previous trial for the application of NASBA real-time monitoring by MBs on the LightCycler system [14] . As the LightCycler system is able to adopt diverse probes and is used in many laboratories, we investigated whether the system could be employed universally as a platform for Aspergillus Q-NASBA.
The variability or unexpected results of Q-NASBA between replicate samples is often observed to be greater than that seen in PCR-based assays. So, for precision and accuracy in predicting unknown concentrations of target RNA, the quantifi cation of NASBA has typically been performed with an external known standard curve [15] , or with the TTP ratio using internal controls [16] . But, our previous study involving one tube NASBA assay with internal controls showed that it is diffi cult to apply to the previous Aspergillus 18s rRNA NASBA in which target NASBA reactions interfered with the reaction of internal controls [17] . Hence, we adopted NASBA assay with external standard curve analysis in this study.
For Aspergillu s diagnostics using NASBA, MBs have been employed in real time monitoring [5, 17] . Despite the usefulness of MBs, it has also been reported that they could be disrupted due to degradation by nucleases, which could in turn result in false positive signals due to non-specifi c interactions [18, 19] . T7 RNA polymerase was also demonstrated to possess nuclease activity against the oligomer of DNA and RNA [20] . This suggests that real time monitoring with MBs in NASBA might carry the risk of false positive results in clinical diagnostics. For the results of MB-NASBA with negative controls (Fig. 2B) , we suggest that the false positivity (or the possibility of artifi cially increased fl uorescence at the end of the test) may be due to the above-mentioned risk of MBs, i.e., they could be easily disrupted by inherent nuclease activity [18, 19] .
Aspergillus 18S rRNA NASBA has been specifi cally designed for the diagnosis of aspergillosis. As clinical specimens usually contain human RNA, if primers or probes of NASBA are homologous to human mRNA or other transcripts, reaction interference could occur. It could result in false negativity, especially at low concentration as in most of clinical specimens. The lower annealing temperature of NASBA than that of PCR could also cause the false negativity. Hence, we have designed a new set of primers and probe which could avoid nonspecifi c interaction with human 18S rRNA as shown in Table 1. FRET-NASBA could provide some benefi ts in the development of other NASBA diagnostics, e.g., for viral and fungal diseases which are diffi cult to diagnose [9 -15] . To increase the performance of NASBA, other probes such as 2 ′ -O -Methyl MBs resistant to linear nuclease [21] or simple (one) probe systems using FRET will also be further analyzed by NASBA assay.
Although the comparison of RNA copies by FRET-with MB-NASBA showed a good correlation in this study, it was rather a minimum evaluation of clinical specimens. To determine the usefulness of FRET-NASBA as an alternative in the diagnosis of invasive aspergillosis, further study using more clinical specimens is necessary. Hence, we are planning to perform a further study on clinical cases to evaluate whether FRET-NASBA could be practically used to predict clinical outcomes and be applied to the clinical diagnostics of invasive aspergillosis.
We thought that our results expanded the practical spectrum of NASBA through the utilization of another probe system like FRET. Moreover, the performance of NASBA for Aspergillus detection on the LightCycler system could be more practical for many laboratories which are not equipped with specialized NASBA instruments. 
